Transparency Market Research Single User License:
USD 4595
Synthetic Biology Market is growing at Multi User License: a CAGR of 32.6% from 2013 to 2019. USD 7595 By Transparency Market Research.
Corporate User License:
USD 10595 Published Date 08-Apr-2014
143 Page Report
Request Sample
Buy Now
Press Release
Global Synthetic Biology Market Expected to Reach USD13.4 Billion in 2019: Transparency Market Research Transparency Market Research State Tower, 90, State Street, Suite 700. Albany, NY 12207 United States www.transparencymarketresearch.com sales@transparencymarketresearch.com
Global Synthetic Biology Market
REPORT DESCRIPTION
Synthetic Biology Market was valued at USD 1.8 billion in 2013 and is estimated to reach a market worth of USD 13.4 billion in 2019 growing at a CAGR of 32.6% from 2013 to 2019.
Synthetic biology is a process where artificial biological devices and systems are produced with the utilization of genetic engineering and biology. It plays an important role in the production ofimproved nutrition or cost effective medicines.Increasing number of scientific research coupled with rising participation of government and private organizations for the development of synthetic biology helps the growth of this market globally.In addition, new product development by key market players in collaboration with other companies will furtherdrive the growth of this market during the study period.
Browse Global Synthetic Biology Market Report with Full TOC at http://www.transparencymarketresearch.com/synthetic-biology-market.html
Rising global marine pollution will also act as a growth driver for the market owing to the fact that synthetic biology helps develop engineered microorganisms that can help curb oil spills and can turn plastics into reusable microplastics. The depleting prices of DNA sequencing act as a growth driver for the market as DNA sequencing is a technology used for developing core products such as synthetic genes and synthetic DNAs. Major market factors restraining the growth of synthetic biology market are ethical issues pertaining to the utilization of synthetic biology products.
Synthetic biology market is mainly segmented by products, by technologies and by applications. The product segment of synthetic biology is further classified as core products and enabling products. Core products market is segmented as synthetic DNA, synthetic genes, synthetic cells,
Transparency Market Research
2
Global Synthetic Biology Market
XNA and chassis organisms. While enabling products are segmented as DNA synthesis and oligonucleotide synthesis products.Compared with synthetic biology enabling products, the core products (synthetic genes, cell's DNA and XNA) are widely used and hence in 2012, core product segment covered major market share.Synthetic biology, by technologies segment is divided into genome engineering, DNA sequencing, bioinformatics and biological components and integrated systems. In 2012, synthetic biology genome engineering technology held major market share, owing to its ability to modify specific area of DNA that helps to offer better reproducibility. Application segment of synthetic biology market is classifiedas healthcare, chemicals, agriculture and others. Synthetic biology has continued to prove its efficiency in the development and production of various inexpensive healthcare products such as vaccines and drugs. Also, commercial availability of synthetic DNA and synthetic genes supports the growth of the healthcare application in the synthetic biology market. Thus, all the above mentioned factors collectively drive the growth of synthetic biology in healthcare application market.
Europe is expected to dominate the synthetic biology market during the forecast period.Increasing efforts of European government and private organizations towards the development of this fieldis the major driving factor for the growth of synthetic biology market in Europe.North America contributed the second largest share of the total market in 2012. Introduction of novel technologies by domiciled key players which expand the scope for the development of this field will help the growth of this market in North America.In addition, one key factor driving the growth of synthetic biology market in developed countries (North America and Europe) is the initiative and funding by the government and universities. For example, SynBERC and TESSY are the initiatives of North American and Europe government, respectively, for the development of synthetic biology sector. The main goal of these organizations is to stimulate the growth of synthetic biology field by promoting awareness in respective countries.
DuPont, Inc., Amyris, Inc. Bayer AG, Royal DSM, Ginkgo Bioworks and Life Technologies Corporation (Thermo Fisher Scientific) are the key players having maximum presence in the global synthetic biology market. The global synthetic biologymarket is segmented as follows: Synthetic Biology Market, by Products Core Products
Transparency Market Research
3
Global Synthetic Biology Market
Synthetic Biology Market, by Technologies Genome Engineering DNA Sequencing Bioinformatics Biological Components and Integrated Systems Synthetic Biology Market, by Applications Healthcare Chemicals (Including Bio-Fuels) Agriculture Others (Biosecurity, R&D, Energy and Environment) Synthetic Biology Market, by Geography North America Europe Asia-Pacific Rest of the World (RoW)
For Sample Report Visit On: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=421 TABLE OF CONTENT
Chapter 1 Introduction 1.1 Report Description
Transparency Market Research
4
Global Synthetic Biology Market
1.2 Market Segmentation 1.3 Research Methodology 1.4 List of Abbreviations
Chapter 2 Executive Summary 2.1 Market Snapshot: Global Synthetic Biology Market (2012 & 2019) 2.1.1 Global Synthetic Biology Market by Technologies, 2012 (USD Million) 2.2 Comparative Analysis: Global Synthetic Biology Market, By Geography, 2012 and 2019 (Value %)
Chapter 3 Market Overview 3.1 Introduction 3.2 Market Drivers 3.2.1 Drivers 3.2.1.1 Rising demand for improved drugs and vaccines 3.2.1.2 Advancement in molecular biology 3.2.1.3 Encouragement and participation of government bodies and universities in synthetic biology research 3.2.1.4 Increasing demand of genetically modified crops due to rising population 3.3 Market Restraints 3.3.1 Ethical Issues
Transparency Market Research
5
Global Synthetic Biology Market
3.4 Market Opportunities 3.4.1 Increasing clarity about metabolic pathways and nascent nature of synthetic biology concepts 3.5 Porter’s Five Force Analysis 3.5.1 Bargaining Power of Suppliers 3.5.2 Bargaining Power of Buyers 3.5.3 Threat of Substitutes 3.5.4 Threat of New Entrants 3.5.5 Competitive Rivalry 3.6 Market Attractiveness Analysis: Global Synthetic Biology Market, by Geography
Chapter 4 Global Synthetic Biology Market, by Products 4.1 Introduction 4.1.1 Global Synthetic Biology Market Revenue, by Products, 2011 – 2019 (USD Million) 4.2 Core Products 4.2.1 Global Core Products Market Revenue, by Types, 2011 – 2019 (USD Million) 4.2.2 Synthetic DNA 4.2.2.1 Global Synthetic DNA Market Revenue, 2011 – 2019 (USD Million) 4.2.3 Synthetic Genes 4.2.3.1 Global Synthetic Genes Market Revenue, 2011 – 2019 (USD Million) 4.2.4 Synthetic Cells
Transparency Market Research
6
Global Synthetic Biology Market
4.2.4.1 Global Synthetic Cells Market Revenue, 2013 – 2019 (USD Million) 4.2.5 XNA (Xeno Nucleic Acid) 4.2.5.1 Global XNA Market Revenue, 2014 – 2019 (USD Million) 4.2.6 Chassis Organisms 4.2.6.1 Global Chassis Organisms Market Revenue, 2015 – 2019 (USD Million) 4.3 Enabling Products 4.3.1 Global Enabling Products Market Revenue, by Types, 2011 – 2019 (USD Million) 4.3.2 DNA Synthesis 4.3.2.1 Global DNA Synthesis Market Revenue, 2011 – 2019 (USD Million) 4.3.3 Oligonucleotide Synthesis 4.3.3.1 Global Oligonucleotide Synthesis Market Revenue, 2011 – 2019 (USD Million)
Chapter 5 Global Synthetic Biology Market, by Technologies 5.1 Introduction 5.1.1 Global Synthetic Biology Market Revenue, by Technologies, 2011 – 2019 (USD Million) 5.2 Genome Engineering 5.2.1 Global Genome Engineering in Synthetic Biology Market Revenue, 2011 – 2019 (USD Million) 5.3 DNA Sequencing 5.3.1 Global DNA Sequencing in Synthetic Biology Market Revenue, 2011 – 2019 (USD Million)
Transparency Market Research
7
Global Synthetic Biology Market
5.4 Bioinformatics 5.4.1 Global Bioinformatics in Synthetic Biology Market Revenue, 2011 – 2019 (USD Million) 5.5 Biological Components and Integrated Systems 5.5.1 Global Biological Components and Integrated Systems in Synthetic Biology Market revenue, 2011 – 2019 (USD Million)
Chapter 6 Global Synthetic Biology Market, by Applications 6.1 Introduction 6.1.1 Global Synthetic Biology Market Revenue, by Applications, 2011 – 2019 (USD Million) 6.2 Chemicals 6.2.1 Global Synthetic Biology in Chemicals, Market Revenue, 2011 – 2019 (USD Million) 6.3 Healthcare 6.3.1 Global Synthetic Biology in Healthcare Market Revenue, 2011 – 2019 (USD Million) 6.4 Agriculture 6.4.1 Global Synthetic Biology in Agriculture Market Revenue, 2011 – 2019 (USD Million) 6.5 Others (Biosecurity, R&D, Energy and Environment) 6.5.1 Global Synthetic Biology in Other Applications Market Revenue, 2011 – 2019 (USD Million)
Chapter 7 Global Synthetic Biology Market, by Geography 7.1 Introduction
Transparency Market Research
8
Global Synthetic Biology Market
7.1.1 Global Synthetic Biology Market Revenue, by Geography, 2011 – 2019 (USD Million) 7.2 North America 7.2.1 North America Synthetic Biology Market Revenue, 2011 – 2019 (USD Million) 7.3 Europe 7.3.1 Europe Synthetic Biology Market Revenue, 2011 – 2019 (USD Million) 7.4 Asia-Pacific 7.4.1 Asia-Pacific Synthetic Biology Market Revenue, 2011 – 2019 (USD Million) 7.5 Rest of the World (RoW) 7.5.1 RoW Synthetic Biology Market Revenue, 2011 – 2019 (USD Million)
Chapter 8 Competitive Landscape 8.1 Heat Map Analysis for Key Market Players 8.1.1 Amyris, Inc. 8.1.2 DuPont, Inc. 8.1.3 Royal DSM 8.1.4 Evolva Holding 8.1.5 Life Technologies Corporation 8.2 Heat Map Analysis of the Synthetic Biology Market, by Key Market Players, 2013 Chapter 9 Recommendations 9.1 Market Strategy for Success
Transparency Market Research
9
Global Synthetic Biology Market
9.1.1 Focus on investing in research and development activities 9.1.2 Strategic alliance, mergers and acquisitions 9.2 Barriers to be Considered 9.2.1 Ethical issues associated with synthetic biology products Chapter 10 Company Profiles 10.1 Agrivida, Inc. 10.1.1 Company Overview 10.1.2 Financial Overview 10.1.3 Product Portfolio 10.1.4 Business Strategies 10.1.5 Recent Developments 10.2 Amyris, Inc. 10.2.1 Company Profile 10.2.2 Financial Overview 10.2.3 Product Portfolio 10.2.4 Business Strategies 10.2.5 Recent Developments 10.3 Algenol Biofuels, Inc. 10.3.1 Company Overview 10.3.2 Financial Overview
Transparency Market Research
10
Global Synthetic Biology Market
10.3.3 Product Portfolio 10.3.4 Business Strategies 10.3.5 Recent Developments 10.4 ATG:biosynthetics GmbH 10.4.1 Company Overview 10.4.2 Financial Overview 10.4.3 Product Portfolio 10.4.4 Business Strategies 10.4.5 Recent Developments 10.5 Bayer AG 10.5.1 Company Overview 10.5.2 Financial Overview 10.5.3 Product Portfolio 10.5.4 Business Strategies 10.5.5 Recent Developments 10.6 Bristol-Myers Squibb 10.6.1 Company Overview 10.6.2 Financial Overview 10.6.3 Product Portfolio 10.6.4 Business Strategies
Transparency Market Research
11
Global Synthetic Biology Market
10.6.5 Recent Developments 10.7 BIONEER CORPORATION 10.7.1 Company Overview 10.7.2 Product Portfolio 10.7.3 Business Strategies 10.7.4 Recent Developments 10.8 Biosearch Technologies, Inc. 10.8.1 Company Overview 10.8.2 Financial Overview 10.8.3 Product Portfolio 10.8.4 Business Strategies 10.8.5 Recent Developments 10.9 CBC Comprehensive Biomarker Center GmbH 10.9.1 Company Overview 10.9.2 Financial Overview 10.9.3 Product Portfolio 10.9.4 Business Strategies 10.9.5 Recent Developments 10.10 Cobalt Technologies 10.10.1 Company Overview
Transparency Market Research
12
Global Synthetic Biology Market
10.10.2 Financial Overview 10.10.3 Product Portfolio 10.10.4 Business Strategies 10.10.5 Recent Developments 10.11 DuPont, Inc. 10.11.1 Company Overview 10.11.2 Financial Overview 10.11.3 Product Portfolio 10.11.4 Business Strategies 10.11.5 Recent Developments 10.12 Evolva SA 10.12.1 Company Overview 10.12.2 Financial Overview 10.12.3 Product Portfolio 10.12.4 Business Strategies 10.12.5 Recent Developments 10.13 Exxon Mobil Corporation 10.13.1 Company Overview 10.13.2 Financial Overview 10.13.3 Product Portfolio
Transparency Market Research
13
Global Synthetic Biology Market
10.13.4 Business Strategies 10.13.5 Recent Developments 10.14 Ginkgo Bioworks 10.14.1 Company Overview 10.14.2 Financial Overview 10.14.3 Product Portfolio 10.14.4 Business Strategies 10.14.5 Recent Developments 10.15 GeneWorks Pty Ltd. 10.15.1 Company Overview 10.15.2 Financial Overview 10.15.3 Product Portfolio 10.15.4 Business Strategies 10.15.5 Recent Developments 10.16 Genomatica, Inc. 10.16.1 Company Overview 10.16.2 Financial Overview 10.16.3 Product Portfolio 10.16.4 Business Strategies 10.16.5 Recent Developments
Transparency Market Research
14
Global Synthetic Biology Market
10.17 GeneScript Corporation 10.17.1 Company Overview 10.17.2 Financial Overview 10.17.3 Product Portfolio 10.17.4 Business Strategies 10.17.5 Recent Developments 10.18 Gevo, Inc. 10.18.1 Company Overview 10.18.2 Financial Overview 10.18.3 Product Portfolio 10.18.4 Business Strategies 10.18.5 Recent Developments 10.19 Green Biologics Limited 10.19.1 Company Overview 10.19.2 Financial Overview 10.19.3 Product Portfolio 10.19.4 Business Strategies 10.19.5 Recent Developments 10.20 New England Biolabs, Inc. 10.20.1 Company Overview
Transparency Market Research
15
Global Synthetic Biology Market
10.20.2 Financial Overview 10.20.3 Product Portfolio 10.20.4 Business Strategies 10.20.5 Recent Developments 10.21 OriGene Technologies, Inc. 10.21.1 Company Overview 10.21.2 Financial Overview 10.21.3 Product Portfolio 10.21.4 Business Strategies 10.21.5 Recent Developments 10.22 REG Life Sciences, LLC 10.22.1 Company Overview 10.22.2 Financial Overview 10.22.3 Product Portfolio 10.22.4 Business Strategies 10.22.5 Recent Developments 10.23 Royal DSM 10.23.1 Company Overview 10.23.2 Financial Overview 10.23.3 Product Portfolio
Transparency Market Research
16
Global Synthetic Biology Market
10.23.4 Business Strategies 10.23.5 Recent Developments 10.24 Thermo Fisher Scientific, Inc. 10.24.1 Company Overview 10.24.2 Financial Overview 10.24.3 Product Portfolio 10.24.4 Business Strategies 10.24.5 Recent Developments
About Us Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forwardlooking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge. Contact: Transparency Market Research 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free 866-552-3453 Email: sales@transparencymarketresearch.com Website: http://www.transparencymarketresearch.com/
Transparency Market Research
17